Article Details
Retrieved on: 2018-02-20 00:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Among 11 analysts covering Achillion Pharma (NASDAQ:ACHN), 6 have Buy rating, 0 Sell and 5 Hold. Therefore 55% are positive. Achillion Pharma had 26 analyst reports since August 13, 2015 according to SRatingsIntel. On Wednesday, February 7 the stock rating was initiated by FBR Capital with ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here